1. Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical School, Rostock, Germany;
2. Cytognos SL, Salamanca, Spain;
3. FACS/Stem Cell Laboratory, Kantonsspital Aarau AG, Aarau, Switzerland;
4. Secção de Citometria de Fluxo, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal;
5. Clinical and Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain;
6. Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain;
7. Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain;
8. Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands;
9. CLIP - Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic;
10. Department of Diagnostic Sciences, Ghent University, Ghent, Belgium;
11. Department of Internal Medicine II, University of Schleswig-Holstein, Kiel, Germany;
12. Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC CB16/12/00369, Pamplona, Spain;
13. Department of Immunology, Leiden University Medical Center, Leiden, Netherlands; and
14. Systems and Computing Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil